{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:04:19Z","timestamp":1790337859523,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2024-00452747"],"award-info":[{"award-number":["RS-2024-00452747"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2026-25478487"],"award-info":[{"award-number":["RS-2026-25478487"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2025-02218875"],"award-info":[{"award-number":["RS-2025-02218875"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Materials Today Bio"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.mtbio.2026.103600","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:47:07Z","timestamp":1787701627000},"page":"103600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer"],"prefix":"10.1016","volume":"40","author":[{"given":"Youngri","family":"Ryu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hochung","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junha","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeongmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2192-800X","authenticated-orcid":false,"given":"Wonjun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3242-3633","authenticated-orcid":false,"given":"Hong-Yeol","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Hyuk","family":"Kweon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Kyu","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3279-4362","authenticated-orcid":false,"given":"Yoosoo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.mtbio.2026.103600_bib1","doi-asserted-by":"crossref","first-page":"9555","DOI":"10.3390\/ijms25179555","article-title":"The role of tumor microenvironment in pancreatic cancer immunotherapy: current status and future perspectives","volume":"25","author":"Poyia","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mtbio.2026.103600_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jbior.2017.11.007","article-title":"Molecular and cellular mechanisms of chemoresistance in pancreatic cancer","volume":"68","author":"Adamska","year":"2018","journal-title":"Adv. Bio. Regul."},{"key":"10.1016\/j.mtbio.2026.103600_bib3","first-page":"6","article-title":"Pancreatic cancer and immune checkpoint inhibitors-still a long way to go, translational","volume":"6","author":"Bian","year":"2021","journal-title":"Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103600_bib4","doi-asserted-by":"crossref","first-page":"688","DOI":"10.20892\/j.issn.2095-3941.2019.0252","article-title":"The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview","volume":"16","author":"Qui\u00f1onero","year":"2019","journal-title":"Cancer Biol. Med."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103600_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cells13110948","article-title":"The multifaceted role of miR-21 in pancreatic cancers","volume":"13","author":"Chen","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.mtbio.2026.103600_bib6","article-title":"MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential","volume":"12","author":"Dong","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103600_bib7","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1074\/jbc.M707224200","article-title":"Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells","volume":"283","author":"Frankel","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.mtbio.2026.103600_bib8","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1038\/onc.2010.620","article-title":"Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas","volume":"30","author":"Kwak","year":"2011","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103600_bib9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mtbio.2026.103600_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jconrel.2022.02.031","article-title":"PDL1-binding peptide\/anti-miRNA21 conjugate as a therapeutic modality for PD-L1(high) tumors and TAMs","volume":"345","author":"Kim","year":"2022","journal-title":"J. Contr. Release"},{"issue":"3","key":"10.1016\/j.mtbio.2026.103600_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10555-021-09981-3","article-title":"Next-generation immunotherapy for pancreatic ductal adenocarcinoma: navigating pathways of immune resistance","volume":"40","author":"Heumann","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/s41392-020-00341-1","article-title":"Beyond just a tight fortress: contribution of stroma to epithelial-mesenchymal transition in pancreatic cancer","volume":"5","author":"Bulle","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"17","key":"10.1016\/j.mtbio.2026.103600_bib13","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"18","key":"10.1016\/j.mtbio.2026.103600_bib14","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3748\/wjg.v27.i18.2105","article-title":"Stroma-targeting strategies in pancreatic cancer: past lessons, challenges and prospects","volume":"27","author":"Polani","year":"2021","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.mtbio.2026.103600_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib16","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"3","key":"10.1016\/j.mtbio.2026.103600_bib17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy","volume":"8","author":"Ju","year":"2024","journal-title":"npj Precis. Oncol."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103600_bib19","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1001\/jamaoncol.2019.1588","article-title":"Durvalumab with or without tremelimumab for patients with metastatic pancreatic ductal adenocarcinoma: a phase 2 randomized clinical trial","volume":"5","author":"O'Reilly","year":"2019","journal-title":"JAMA Oncol."},{"issue":"8","key":"10.1016\/j.mtbio.2026.103600_bib20","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/CJI.0b013e3181eec14c","article-title":"Phase 2 trial of single agent ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma","volume":"33","author":"Royal","year":"2010","journal-title":"J. Immunother."},{"issue":"26","key":"10.1016\/j.mtbio.2026.103600_bib21","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.mtbio.2026.103600_bib22","article-title":"Multimodal therapies against pancreatic ductal adenocarcinoma: a review on synergistic approaches toward ultimate nanomedicine treatments","volume":"5","author":"Marzia Conte","year":"2022","journal-title":"Adv. Therapeut."},{"issue":"14","key":"10.1016\/j.mtbio.2026.103600_bib23","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.7150\/thno.97269","article-title":"Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs","volume":"14","author":"Jang","year":"2024","journal-title":"Theranostics"},{"issue":"15","key":"10.1016\/j.mtbio.2026.103600_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ade5041","article-title":"Milk-derived extracellular vesicles protect intestinal barrier integrity in the gut-liver axis","volume":"9","author":"Tong","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.mtbio.2026.103600_bib25","first-page":"138","article-title":"Oral TNF-\u03b1 siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease","volume":"34","author":"Han","year":"2024","journal-title":"Bioact. Mater."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103600_bib26","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.7150\/thno.97755","article-title":"Targeted delivery of anti-miRNA21 sensitizes PD-L1(high) tumor to immunotherapy by promoting immunogenic cell death","volume":"14","author":"Kim","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.mtbio.2026.103600_bib27","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v3.26913","article-title":"Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the international society for extracellular vesicles","volume":"3","author":"L\u00f6tvall","year":"2014","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.mtbio.2026.103600_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib29","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for Extracellular vesicles and update of the MISEV2014 guidelines","volume":"7","author":"Th\u00e9ry","year":"2018","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.mtbio.2026.103600_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-0716-2341-1_16","article-title":"Optimized protocol for plasma-derived extracellular vesicles loading with synthetic miRNA mimic using electroporation","volume":"2504","author":"Pomatto","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib31","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1038\/s41467-021-22126-y","article-title":"Quantitative characterization of extracellular vesicle uptake and content delivery within mammalian cells","volume":"12","author":"Bonsergent","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"npj Precis. Oncol."},{"issue":"12","key":"10.1016\/j.mtbio.2026.103600_bib33","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1172\/JCI127125","article-title":"Suppressing miR-21 activity in tumor-associated macrophages promotes an antitumor immune response","volume":"129","author":"Sahraei","year":"2019","journal-title":"J. Clin. Investig."},{"issue":"23","key":"10.1016\/j.mtbio.2026.103600_bib34","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41388-018-0178-3","article-title":"miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy","volume":"37","author":"Xi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.mtbio.2026.103600_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117162","article-title":"MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer","volume":"242","author":"An","year":"2020","journal-title":"Life Sci."},{"issue":"35","key":"10.1016\/j.mtbio.2026.103600_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202511330","article-title":"CDK4\/6 inhibition induces CD8+ T cell antitumor immunity via MIF-induced functional orchestration of tumor-associated macrophages","volume":"13","author":"He","year":"2026","journal-title":"Adv. Sci."},{"issue":"63","key":"10.1016\/j.mtbio.2026.103600_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abg3551","article-title":"Tumor-draining lymph nodes: at the crossroads of metastasis and immunity","volume":"6","author":"du Bois","year":"2021","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.mtbio.2026.103600_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-29780-1","article-title":"Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns","volume":"8","author":"Manca","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.mtbio.2026.103600_bib39","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.apsb.2021.12.015","article-title":"Milk-derived exosomes exhibit versatile effects for improved oral drug delivery","volume":"12","author":"Wu","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.mtbio.2026.103600_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202202412","article-title":"Antitumor activity of Anti-miR-21 delivered through lipid nanoparticles","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"issue":"10","key":"10.1016\/j.mtbio.2026.103600_bib41","doi-asserted-by":"crossref","first-page":"9731","DOI":"10.1021\/acsnano.5b02471","article-title":"Systemic delivery of Anti-miRNA for suppression of triple negative breast cancer utilizing RNA nanotechnology","volume":"9","author":"Shu","year":"2015","journal-title":"ACS Nano"}],"container-title":["Materials Today Bio"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590006426008458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:37:50Z","timestamp":1790336270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590006426008458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S2590006426008458"],"URL":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103600","relation":{},"ISSN":["2590-0064"],"issn-type":[{"value":"2590-0064","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surface-engineered milk-derived extracellular vesicles enable oral miRNA therapy against immunosuppressive pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Materials Today Bio","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mtbio.2026.103600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103600"}}